Patents by Inventor SUSAN FOY

SUSAN FOY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DETERMINING GENE EDITING EFICIENCIES IN CELLS
    Publication number: 20230136076
    Abstract: Methods of detecting the efficacy and presence of a biologic drug which uses one or more 2A peptide in its manufacture and/or final pharmaceutical formulation.
    Type: Application
    Filed: October 24, 2022
    Publication date: May 4, 2023
    Applicant: Pact Pharma, Inc.
    Inventors: Kyle JACOBY, Barbara Sennino, Susan Foy, Theresa L. Hunter
  • PERSONALIZED NEOANTIGEN-SPECIFIC ADOPTIVE CELL THERAPIES
    Publication number: 20220010274
    Abstract: Methods of genetically engineering NeoTCR Products comprising young T cells and methods of manufacturing such cell products.
    Type: Application
    Filed: September 28, 2021
    Publication date: January 13, 2022
    Applicant: PACT PHARMA, INC.
    Inventors: Barbara Sennino, Kyle Jacoby, Susan Foy, Ines Mende, Stefanie Mandl-Cashman
  • Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor
    Publication number: 20210205429
    Abstract: The present disclosure encompasses therapies, compositions, and methods for treatment of a human cancer patient using a recombinant poxvirus encoding a tumor-associated antigen in combination with one or more agonists or antagonists of immune checkpoint inhibitors.
    Type: Application
    Filed: March 18, 2021
    Publication date: July 8, 2021
    Applicant: Bavarian Nordic A/S
    Inventors: Susan Foy, Stefanie Mandl, Ryan Rountree, Alain Delcayre
  • COMBINED ANTI TUMOR THERAPY WITH A GITR AGONIST AND CPG
    Publication number: 20190263919
    Abstract: The present disclosure relates to methods of using glucocorticoid-induced TNFR-related protein (GITR) agonists as anti-tumor agents, for example in combination with CpG oligodeoxynucleotides. A specific antibody, characterized by its CDRs is described as agonist.
    Type: Application
    Filed: June 30, 2017
    Publication date: August 29, 2019
    Applicant: Five Prime Therapeutics, Inc.
    Inventors: Susan Foy, Thomas Brennan, Danielle Kellar
  • Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
    Publication number: 20170266270
    Abstract: The invention relates to compositions, kits, and methods for cancer therapy using recombinant poxviruses encoding a tumor-associated antigen in combination with antagonists or agonists of immune checkpoint inhibitors.
    Type: Application
    Filed: May 8, 2015
    Publication date: September 21, 2017
    Applicant: Bavarian Nordic A/S
    Inventors: SUSAN FOY, STEFANIE MANDL, RYAN ROUNTREE, ALEX FRANZUSOFF
  • Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of TIM-3
    Publication number: 20170106065
    Abstract: The invention relates to compositions, kits, and methods for cancer therapy using recombinant poxviruses encoding a tumor-associated antigen in combination with a monoclonal antibody against immune checkpoint molecule TIM-3.
    Type: Application
    Filed: May 8, 2015
    Publication date: April 20, 2017
    Applicant: Bavarian Nordic A/S
    Inventors: SUSAN FOY, STEFANIE MANDL, RYAN ROUNTREE
  • Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
    Publication number: 20160271239
    Abstract: The present disclosure encompasses therapies, compositions, and methods for treatment of a human cancer patient using a recombinant poxvirus encoding a tumor-associated antigen in combination with one or more agonists or antagonists of immune checkpoint inhibitors.
    Type: Application
    Filed: October 31, 2014
    Publication date: September 22, 2016
    Applicant: Bavarian Nordic A/S
    Inventors: SUSAN FOY, STEFANIE MANDL, RYAN ROUNTREE, ALAIN DELCAYRE